# A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

> **NCT03120273** · PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 70 (estimated)

## Conditions studied

- Effect of Drugs
- Safety Issues

## Interventions

- **DRUG:** Dexlansoprazole Injection
- **DRUG:** Lansoprazole Injection

## Key facts

- **NCT ID:** NCT03120273
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-05
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-09-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120273, "A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03120273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*